Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2016 1
2017 2
2018 1
2020 2
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
Vergnenegre A, Monnet I, Ricordel C, Bizieux A, Curcio H, Bernardi M, Corre R, Guisier F, Hominal S, Le Garff G, Bylicki O, Locher C, Geier M, Chouaïd C, Robinet G; GFPC team. Vergnenegre A, et al. Lung Cancer. 2023 Apr;178:191-197. doi: 10.1016/j.lungcan.2023.02.020. Epub 2023 Feb 27. Lung Cancer. 2023. PMID: 36868180 Clinical Trial.
Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort.
Calcaianu G, Degoul S, Michau B, Payen T, Gschwend A, Fore M, Iamandi C, Morel H, Oster JP, Bizieux A, Nocent-Ejnaini C, Carvallo C, Romanet S, Goupil F, Leurs A, Legrand MG, Portel L, Claustre J, Calcaianu M, Bresson D, Debieuvre D. Calcaianu G, et al. Respir Med Res. 2022 Nov;82:100933. doi: 10.1016/j.resmer.2022.100933. Epub 2022 Jun 14. Respir Med Res. 2022. PMID: 35905553 Free PMC article.
Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy.
Justeau G, Bailly S, Gervès-Pinquié C, Trzepizur W, Meslier N, Goupil F, Pigeanne T, Launois S, Leclair-Visonneau L, Masson P, Bizieux-Thaminy A, Racineux JL, Gozal D, Gagnadoux F; ERMES Study Group. Justeau G, et al. Eur Respir J. 2022 Apr 7;59(4):2101935. doi: 10.1183/13993003.01935-2021. Print 2022 Apr. Eur Respir J. 2022. PMID: 34475228 Free article.
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study).
Auliac JB, Monnet I, Bizieux A, Greillier L, Geier M, Falchero L, Le Garff G, Lamy R, Guisier F, Ricordel C, Chouaid C, Vergnenegre A; REFRACT GFPC 02-15 investigators. Auliac JB, et al. Lung Cancer. 2021 Nov;161:122-127. doi: 10.1016/j.lungcan.2021.09.007. Epub 2021 Sep 20. Lung Cancer. 2021. PMID: 34583220 Clinical Trial.
Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.
Grimaldi-Bensouda L, Danchin N, Dallongeville J, Falissard B, Furber A, Cottin Y, Bonello L, Morel O, Leclercq F, Puymirat E, Ghanem F, Delarche N, Benichou J, Abenhaim L; PGRx-Acute Coronary Syndrome Study Group. Grimaldi-Bensouda L, et al. Heart. 2018 Oct;104(19):1583-1592. doi: 10.1136/heartjnl-2017-312534. Epub 2018 Mar 13. Heart. 2018. PMID: 29535227
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Dhamelincourt E, Descourt R, Rousseau-Bussac G, Doubre H, Decroisette C, Demontrond P, Le Garff G, Falchero L, Huchot E, Vieillot S, Corre R, Kazulinski L, Bizieux A, Bigay-Gamé L, Morel H, Molinier O, Chouaïd C, Guisier F. Dhamelincourt E, et al. Target Oncol. 2023 Nov;18(6):905-914. doi: 10.1007/s11523-023-01014-z. Epub 2023 Nov 15. Target Oncol. 2023. PMID: 37966566
16 results